CD8A and neoplasm: Interestingly, metformin, another well-known anti-diabetic drug, showed similar antitumor effect through inducing the number of CD8+ tumor-infiltrating lymphocytes (TILs) and protected them from apoptosis and exhaustion characterized by decreased production of IL-2, TNF-α, and IFN-γ17.